F. Berthou

5.1k total citations
119 papers, 4.3k citations indexed

About

F. Berthou is a scholar working on Pharmacology, Biochemistry and Spectroscopy. According to data from OpenAlex, F. Berthou has authored 119 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pharmacology, 30 papers in Biochemistry and 29 papers in Spectroscopy. Recurrent topics in F. Berthou's work include Pharmacogenetics and Drug Metabolism (57 papers), Eicosanoids and Hypertension Pharmacology (27 papers) and Analytical Chemistry and Chromatography (26 papers). F. Berthou is often cited by papers focused on Pharmacogenetics and Drug Metabolism (57 papers), Eicosanoids and Hypertension Pharmacology (27 papers) and Analytical Chemistry and Chromatography (26 papers). F. Berthou collaborates with scholars based in France, United States and Chile. F. Berthou's co-authors include Yvonne Dréano, Danièle Lucas, Philippe Beaune, D. Picart, J.F. Ménez, C. Riché, Yolande Amet, H.H. Floch, Jean‐François Ménez and L. Bardou and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Methods in enzymology on CD-ROM/Methods in enzymology and Journal of Lipid Research.

In The Last Decade

F. Berthou

118 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Berthou France 39 1.9k 1.2k 697 636 471 119 4.3k
John R. Bend United States 41 2.1k 1.1× 1.8k 1.6× 1.2k 1.8× 771 1.2× 495 1.1× 172 5.7k
Gerard J. Mulder Netherlands 41 1.4k 0.7× 2.5k 2.1× 666 1.0× 1.0k 1.6× 412 0.9× 179 5.1k
Markku Pasanen Finland 37 1.9k 1.0× 1.3k 1.1× 370 0.5× 932 1.5× 323 0.7× 138 4.8k
Takashi Iyanagi Japan 39 2.2k 1.2× 3.0k 2.6× 444 0.6× 1.2k 1.8× 338 0.7× 85 6.2k
Judy L. Raucy United States 37 3.3k 1.8× 1.6k 1.4× 709 1.0× 1.8k 2.8× 462 1.0× 62 5.4k
Jerome M. Lasker United States 40 2.6k 1.4× 1.1k 1.0× 1.2k 1.7× 1.0k 1.6× 501 1.1× 62 4.9k
Henry W. Strobel United States 42 3.4k 1.8× 2.3k 2.0× 1.0k 1.4× 1.5k 2.4× 491 1.0× 159 6.0k
Burhan I. Ghanayem United States 37 2.2k 1.2× 1.1k 0.9× 766 1.1× 1.2k 1.9× 1.1k 2.3× 94 5.6k
Yvonne Dréano France 30 1.1k 0.6× 613 0.5× 579 0.8× 387 0.6× 313 0.7× 59 2.7k
Gilbert J. Mannering United States 35 2.3k 1.3× 1.2k 1.1× 605 0.9× 839 1.3× 300 0.6× 126 3.9k

Countries citing papers authored by F. Berthou

Since Specialization
Citations

This map shows the geographic impact of F. Berthou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Berthou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Berthou more than expected).

Fields of papers citing papers by F. Berthou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Berthou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Berthou. The network helps show where F. Berthou may publish in the future.

Co-authorship network of co-authors of F. Berthou

This figure shows the co-authorship network connecting the top 25 collaborators of F. Berthou. A scholar is included among the top collaborators of F. Berthou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Berthou. F. Berthou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fer, Maude, Sophie Goulitquer, Yvonne Dréano, et al.. (2006). Determination of polyunsatured fatty acid monoepoxides by high performance liquid chromatography–mass spectrometry. Journal of Chromatography A. 1115(1-2). 1–7. 18 indexed citations
2.
3.
Berthoux, P, et al.. (2002). Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1R and ecNOS. Clinical Nephrology. 57(3). 192–200. 29 indexed citations
4.
Quiñones, Luis A., Danièle Lucas, J. Godoy, et al.. (2001). CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Letters. 174(1). 35–44. 103 indexed citations
5.
6.
Quiñones, Luis A., F. Berthou, Nelson Varela, et al.. (1999). Ethnic susceptibility to lung cancer: differences in CYP2E1, CYP1A1 and GSTM1 genetic polymorphisms between French Caucasian and Chilean populations. Cancer Letters. 141(1-2). 167–171. 53 indexed citations
7.
Adas, Fadi, D. Picart, F. Berthou, Simon Bernard Iloki Assanga, & Yolande Amet. (1998). Liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of ω- and (ω-1)-hydroxylated metabolites of elaidic and oleic acids in human and rat liver microsomes. Journal of Chromatography B Biomedical Sciences and Applications. 714(2). 133–144. 20 indexed citations
8.
Pageaux, Georges‐Philippe, F. Berthou, N Bressot, et al.. (1998). Effects of interferon-α on cytochrome P-450 isoforms 1A2 and 3A activities in patients with chronic hepatitis C. European Journal of Gastroenterology & Hepatology. 10(6). 491–496. 13 indexed citations
9.
Amet, Yolande, et al.. (1997). Noninvolvement of CYP2E1 in the (ω-1)-hydroxylation of fatty acids in rat kidney microsomes. Biochemical Pharmacology. 54(8). 947–952. 11 indexed citations
10.
Bellec, Gwénaëlle, J.-M. Cauvin, Yvonne Dréano, et al.. (1996). Analysis of N-nitrosamines by high-performance liquid chromatography with post-column photohydrolysis and colorimetric detection. Journal of Chromatography A. 727(1). 83–92. 31 indexed citations
11.
Bellec, Gwénaëlle, Yvonne Dréano, P Lozac’h, J.F. Ménez, & F. Berthou. (1996). Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human livermicrosomes. Carcinogenesis. 17(9). 2029–2034. 66 indexed citations
12.
Amet, Yolande, et al.. (1995). Validation of the (ω-l)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. Biochemical Pharmacology. 50(11). 1775–1782. 35 indexed citations
13.
Goasduff, Thierry, J.F. Ménez, Yvonne Dréano, & F. Berthou. (1995). CYP1A2 and 2E1 Expression in Rat Liver Treated with Combined Inducers (3-Methylcholanthrene and Ethanol). Biochemical and Biophysical Research Communications. 211(2). 497–503. 11 indexed citations
14.
Mapoles, John, F. Berthou, Alice Alexander, Francis R. Simon, & Jean‐François Ménez. (1993). Mammalian PC‐12 cell genetically engineered for human cytochrome P450 2E1 expression. European Journal of Biochemistry. 214(3). 735–745. 27 indexed citations
15.
Berthou, F. & Yvonne Dréano. (1993). High-performance liquid chromatographic analysis of tamoxifen, toremifene and their major human metabolites. Journal of Chromatography B Biomedical Sciences and Applications. 616(1). 117–127. 29 indexed citations
16.
Berthou, F., B. Guillois, C. Riché, et al.. (1992). Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica. 22(6). 671–680. 101 indexed citations
17.
Dréano, Yvonne, et al.. (1991). Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochemical Pharmacology. 41(12). 1911–1919. 162 indexed citations
18.
Berthou, F., et al.. (1991). Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes.. Drug Metabolism and Disposition. 19(3). 561–567. 111 indexed citations
19.
Berthou, F., et al.. (1988). Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes. Biochemical Pharmacology. 37(19). 3691–3700. 51 indexed citations
20.
Berthou, F., et al.. (1982). [Specificity of methods for theophylline in biological samples: therapeutic consequences (author's transl)].. PubMed. 37(1). 53–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John R. Bend Breakdown of academic impact, for papers by Gerard J. Mulder Breakdown of academic impact, for papers by Markku Pasanen Breakdown of academic impact, for papers by Takashi Iyanagi Breakdown of academic impact, for papers by Judy L. Raucy Breakdown of academic impact, for papers by Jerome M. Lasker Breakdown of academic impact, for papers by Henry W. Strobel Breakdown of academic impact, for papers by Burhan I. Ghanayem Breakdown of academic impact, for papers by Yvonne Dréano Breakdown of academic impact, for papers by Gilbert J. Mannering
Rankless by CCL
2026